A Randomized Phase II Trial of Atezolizumab With or Without Bevacizumab in Cisplatin-ineligible Patients With Advanced/Unresectable Urothelial Cancer
Phase of Trial: Phase II
Latest Information Update: 16 Oct 2017
At a glance
- Drugs Atezolizumab (Primary) ; Bevacizumab (Primary)
- Indications Urogenital cancer
- Focus Therapeutic Use
- 11 Oct 2017 Status changed from not yet recruiting to recruiting.
- 09 Jun 2017 Planned initiation date changed from 1 May 2017 to 1 Sep 2017.
- 02 May 2017 New trial record